Shawview Consulting has strategic partnerships with several individuals and organisations who are available to work on projects with Shawview. Current partners with Shawview include those listed here.
Public affairs and government relations consultant
Donna has over twenty-five years’ experience in corporate public affairs management and public policy. Trading as Astute Advocacy, Donna is delighted to collaborate with Shawview. She provides a range of services to improve business value for health leaders including government relations advice, stakeholder engagement plans and campaigns, strategic policy and corporate affairs advice, executive coaching, association management support, and she produces a weekly political bulletin. Prior roles include head of Public Affairs for Medicines Australia, COO and Company Secretary for both the National Pharmaceutical Services Association and the Hearing Care Industry Association, manager of government relations for Australia’s premier science agency the CSIRO, and federal government relations for an airline in Australia. She was policy director in the Department of the Prime Minister & Cabinet and worked within a Cabinet Minister’s office. Donna holds a BSocSc (Hons) from UNSW, is a graduate of the Australian Institute of Company Directors and is a long-time member of the National Press Club of Australia.
Policy, legal and strategy consultant
Andrew Jenner is Executive Director of Jenner Strategic Consulting offering offers experienced public affairs and business consultancy services. Before forming Jenner Strategic Consulting in 2014 based in the UK, Andrew was Executive Director of Corporate Strategy & Legal Affairs at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva. Prior to this Andrew was Head of Trade and Development for the UK Government’s Intellectual Property Office (IPO), where he led the UK Government delegation to the World Trade Organization and the World Intellectual Property Organization, as well as being the principal EU negotiator on the World Health Organization’s negotiations on Public Health, Innovation and IP. Andrew holds a Bachelor of Engineering degree with honours, a Diploma in Law and Intellectual Property and Master of Laws from the University of Wales.
Public affairs and ESG communications consultant
Unjela has extensive global experience in leadership roles in Public Affairs and Communications in diverse organizations such as Nestle, UN Office of Project Services (UNOPS), The World Bank, International Federation of Pharmaceutical Manufacturer & Association (IFPMA), Overseas Investors Chamber (OICCI), Dow Jones, British Broadcasting Corporation. Based in Geneva, she has had a career spread over 20 years across Oceania, Europe, Africa, MENA , and Asia. Unjela has extensive experience in helping organizations optimise their value proposition through the development and implementation of ESG and purpose focused communications & advocacy strategies. She is skilled in team development, has significant experience in crisis and media management and is highly adept in public speaking, Unjela has managed small and large multicultural teams and led high-level international delegations, served on company boards, leadership teams and publicly represented organisations as a spokesperson. Unjela has a double Masters in Mass Communication and Gender Studies from SOAS, University of London. She was also the first female CEO of an international chamber of commerce in Asia.
Global health consultant
Evan Lee is a Geneva-based consultant and an expert in global health policy. He has previously worked for pharmaceutical company Eli Lilly as Vice President Global Health and Programs, the Senior Adviser to Foundation for Innovative New Diagnostics (FIND), a consultant with Management Sciences for Health and Medical Coordinator with Medicines Sans Frontieres. He has worked on many global health and access to medicines issues including diabetes, cardiovascular disease in low- and middle-income countries, public affairs and business strategy. A medically qualified doctor by training, he has a BA in chemistry and physics from Harvard University, a medical degree from New York University School of Medicine and an MBA from Massachusetts Institute of Technology.
Jorge Mestre-Ferrandiz is an independent economics consultant, based in Madrid, Spain, having spent 15 years at The Office of Health Economics with various positions including as an Industrial Economist and as Director of Consulting. Jorge has over 15 years’ experience consulting to the pharmaceutical industry and related non-profit organisations and his clients have included a number of global top 30 pharmaceutical companies and a range of NGOs. He specialises in the economics of the industry, the pricing and reimbursement of medicines, the impact of public policy on innovation, market access, the economics of antimicrobial resistance (AMR), and pharmaceutical product portfolios. Jorge has a PhD in Economic Analysis from the University Autonoma of Barcelona, has published over 50 papers on health economics and is regularly invited to speak on related topics at academic and commercial international conferences. He is a Visiting Fellow at OHE, Director, Oxford Martin Programme on Affordable Medicines, Oxford Martin School, University of Oxford, an Honorary Visiting Lecturer at the Department of Economics, City University London, and Health Economics Professor at Instituto de Empresa (IE) Business School, Madrid.
Rob has over 20 years’ experience advising health and medical technology companies on market entry, M&A, business planning, investment and venture capital raising in the Chinese health market. He has previously worked in related senior roles for EY, Austrade and the Queensland state government. For the last 10 years, Rob has run an advisory business based in Shanghai for life sciences and medical technology companies seeking to enter China and Chinese investment funds. Rob has worked with clients to navigate the complex and evolving Chinese life sciences market and regulatory landscape. He advises in market entry; due diligence; partner development; distribution, contract and licence negotiation; commercialisation; clinical trial and regulatory support. Rob is a member of the Australian Institute of Company Directors and formerly Executive Director of the Australia-China Business Council. He holds an MBA from Griffith University and a Master of Public Health from the Queensland University of Technology.
Regulatory, Medical and Pharmacovigilance Global Policy Consultant
Sunayana Shah is an expert in regulatory, scientific, medical, pharmacovigilance policy and issues at national and international level. Based in London, she has extensive experience in complex stakeholder management, policy analysis and communication, particularly in complex technical scientific areas. Sunayana previously was Head of Regulatory and Safety Policy at the Association of the British Pharmaceutical Industry (ABPI) where she advised the pharmaceutical industry and worked with UK, European and international agencies on international regulatory policy issues, including Brexit. Previously, she led scientific and medical affairs at the Proprietary Association of Great Britain (PAGB) leading on national and international OTC policy, regulatory issues and professional programs. She has also been Senior Staff editor of the British National Formulary, Royal Pharmaceutical Society and has extensive community pharmacy experience. Sunayana holds an honours degree from the School of Pharmacy, University of London, and Post Graduate Diplomas in Evidence based Pharmacotherapy (Aston University) and Community Pharmacy (University of Keele). She is a GPhC registered pharmacist and a Fellow and Ambassador of the Royal Pharmaceutical Society.
Vince Vo is a Consultant with Shawview Consulting and an experienced health economist, policy expert and government affairs professional. Based in Melbourne, Vince works both as an economist, undertaking policy analysis, economic and health policy research, health economic evaluations, and providing government affairs services to the public and private sectors. He has previously held research and teaching positions at the Centre for Health Economics at Monash University and the University of Queensland, the CSIRO, and Cornwalls Law. Previously, he worked in government affairs for the American Chamber of Commerce in Vietnam and Australia, and in public affairs with Coca-Cola Vietnam. Vince holds an economics degree from the Foreign Trade University (Vietnam), a law degree from the University of Law (Vietnam), and a Master of Economics and Public Policy from the University of Queensland (Dean’s Honour Roll). He is completing his PhD in health economics at the Monash Business School on artificial intelligence in healthcare.
Kangping (Bill) Zhou
Kangping (Bill) Zhou is an Associate Consultant with Shawview Consulting. Based in Sydney, Bill undertakes a variety of policy and research projects on topics such as global health policy, regulatory policy, medicines, clinical trials, genomics and Chinese health and pharmaceutical policy. He is in his fourth year of a Bachelor of Science (Medical Science) (Honours) at the University of Sydney.
Our Corporate Partners
PharmaSymbiosis is a specialist African consulting and services company providing a variety of services to the health and pharmaceutical sector. The firm helps clients address health care challenges, access opportunities, and to compete more effectively in African markets through the services including market research, consulting, product life cycle management, marketing, regulatory, health policy support, pharmacovigilance and public health initiative support. PharmaSymbiosis operates in Ghana, Ivory Coast, Kenya, Nigeria and Sierra Leone.